Serina Therapeutics (SER) EBITDA Margin (QoQ) (2018 - 2024)
Serina Therapeutics (SER) EBITDA Margin (QoQ) (2018 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.82 Bn | 131.97 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.70 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.23 Bn | 60.05 Bn | 1.37 Bn |
| 4 | Moderna | 60.16 Bn | 55.02 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.16 Bn | 37.07 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.86 Bn | 28.55 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.24 Bn | 9.85 Bn | 668.28 Mn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - |
| 10 | Serina Therapeutics | 43.44 Mn | 20.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 7.76 Mn |
| Sep 30, 2024 | -3.04 Mn |
| Jun 30, 2024 | 3.88 Mn |
| Mar 31, 2024 | -4.64 Mn |
| Dec 31, 2023 | 505,263.00 |
| Sep 30, 2023 | 845,517.00 |
| Jun 30, 2023 | -1.03 Mn |
| Mar 31, 2023 | 1.91 Mn |
| Dec 31, 2022 | -505,278.00 |
| Sep 30, 2022 | -396,389.00 |
| Jun 30, 2022 | 2.78 Mn |
| Mar 31, 2022 | -3.99 Mn |
| Dec 31, 2021 | 580,812.00 |
| Sep 30, 2021 | -101,554.00 |
| Jun 30, 2021 | -205,410.00 |
| Mar 31, 2021 | -243,257.00 |
| Dec 31, 2020 | 200,113.00 |
| Sep 30, 2020 | 178,831.00 |
| Jun 30, 2020 | -188,245.00 |
| Mar 31, 2020 | -288,506.00 |